ArticleInternational journal of cancer2026

Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE.

Karin Potthoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.